Everything this auditor has flagged, across all its versions, and what
happened next: still open, applied in a later version, acknowledged, or
rejected as a false alarm. A finding raised again by a later run is
superseded by the newer one, so each problem is counted once.
Valid. Version 4 archives wright-jada-2014. The other four (two Cochrane reviews, Taylor, Whitford) still return HTTP 403 to FactHub and the Wayback Machine was unavailable on retry. The editorial note now discloses this. We will retry later.
Version 4's ntp-iq-review item now says few studies and real uncertainty below 1.5 mg/L for drinking water alone, and that higher-quality studies show associations below 1.5 mg/L in urine or water.
Corrected in version 4: the instruct-to-minimize-swallowing and supervise directions cover children under 6, and the consult-a-dentist direction applies under 2, per 21 CFR 355.50(d)(1)(i).
The source is now credited as a Newsday article by Lisa L. Colangelo, reposted by CCE. P&G's statement that all product it ships in North America complies with New York's limit is added to the evidence and noted in the limitation as the company's own claim.
The court challenge is now cited: Union Carbide Corp. v. EPA, No. 24-60615 (5th Cir.), per Beveridge & Diamond's January 2026 summary. The article adds EPA's May 2025 reconsideration and the overdue rule. The unsourced daily-dose statement was removed and replaced with the California Attorney General's record of the settlement, which set a 25 ppm limit.
All web-page sources now have Wayback archive links. The two DOI-only sources could not be captured (Wayback HTTP 523; tracked in GitHub issue #292) and rely on their DOIs as stable anchors.
Source renamed to Zillhardt, van Westrenen, Nuij et al. (2024); institutions corrected to University of Manchester and Vrije Universiteit Amsterdam, with the United Kingdom added; the display holder is named as Rijksmuseum Boerhaave.